- Country: Tunisia
- Summary: Bivacizumab FL INJ 100 mg
- TNT Ref No: 59495802
- Deadline: 06 Dec 2021
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: C8-2021
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Tenders are invited for Bivacizumab FL INJ 100 mg Method of Procurement: Open call for tenders Notice No AO: 20211100119-00 Date and Time of the Start of Sending Offers: 04-11-2021 09:00 Last Deadline for Receipt of Tenders: 06-12-2021 09:00 Date and Time of Opening of Tenders: 06-12-2021 11:00 Lot No: 1 Title: Bivacizumab FL INJ 100 mg Bond: 0 TND Lot No: 2 Title: Bivacizumab FLJ 400 mg Bond: 0 TND Lot No: 3 Title: Temozolomide gelule 5 mg Bond: 0 TND [Disclaimer: The above text is machine translated. For accurate information kindly refer the original document.]
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINBivacizumab FL INJ 100 mg - Tunisian Tender
The PHARMACIE CENTRALE DE TUNISIE, a Government sector organization in Tunisia, has announced a new tender for Bivacizumab FL INJ 100 mg. This tender is published on TunisianTenders under TNT Ref No: 59495802 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2021-12-06.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
